Kindstar Globalgene Technology, Inc. Stock price

Equities

9960

KYG5262E1044

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
1.47 HKD +4.26% Intraday chart for Kindstar Globalgene Technology, Inc. +4.26% -12.50%

Financials

Sales 2023 967M 134M 1.05B Sales 2024 * 1.32B 183M 1.43B Capitalization 1.3B 180M 1.41B
Net income 2023 41M 5.68M 44.44M Net income 2024 * 110M 15.24M 119M EV / Sales 2023 1.51 x
Net cash position 2023 * - 0 0 Net cash position 2024 * - 0 0 EV / Sales 2024 * 0.99 x
P/E ratio 2023
35.9 x
P/E ratio 2024 *
12.3 x
Employees 3,214
Yield 2023 *
-
Yield 2024 *
-
Free-Float 53.27%
More Fundamentals * Assessed data
Dynamic Chart
Kindstar Globalgene Technology, Inc. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 27 September 2024 CI
Kindstar Globalgene Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Kindstar Globalgene Arm to Setup 300 Million Yuan PE Fund MT
Kindstar Globalgene Technology, Inc.(SEHK:9960) dropped from S&P Global BMI Index CI
Kindstar Globalgene Logs 31% Drop in H1 Income MT
Kindstar Globalgene Technology, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Kindstar Globalgene Units form Partnership with Two Parties to Boost Investment Income MT
Kindstar Globalgene Technology, Inc. commences an Equity Buyback Plan for 99,051,118 shares, representing 10% of its issued share capital, under the authorization approved on June 1, 2023. CI
Kindstar Globalgene Technology, Inc.'s Equity Buyback announced on June 23, 2022, has expired. CI
Kindstar Globalgene Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Kindstar Trustee Buys 13 Million Shares in Nine Months Through September MT
Kindstar Globalgene Technology, Inc.(SEHK:9960) added to S&P Global BMI Index CI
Kindstar Globalgene Swings to H1 Profit MT
Kindstar Globalgene Technology, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Kindstar Globalgene Technology, Inc. Announces Executive Changes CI
More news
1 day+4.26%
1 week+4.26%
Current month+3.52%
1 month+2.08%
3 months-14.04%
6 months-8.12%
Current year-12.50%
More quotes
1 week
1.40
Extreme 1.4
1.50
1 month
1.38
Extreme 1.38
1.50
Current year
1.38
Extreme 1.38
1.79
1 year
1.38
Extreme 1.38
2.21
3 years
1.38
Extreme 1.38
9.78
5 years
1.38
Extreme 1.38
9.78
10 years
1.38
Extreme 1.38
9.78
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 11-02-21
Director of Finance/CFO 46 20-12-03
Chief Operating Officer 52 20-12-03
Members of the board TitleAgeSince
Director/Board Member 58 12-01-29
Director/Board Member 59 21-02-22
Chief Executive Officer 66 11-02-21
More insiders
Date Price Change Volume
24-03-28 1.47 +4.26% 826,000
24-03-27 1.41 0.00% 31,000
24-03-26 1.41 -2.08% 41,000
24-03-25 1.44 +2.86% 59,500
24-03-22 1.4 -0.71% 54,000

Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT

More quotes
Kindstar Globalgene Technology Inc is a China-based investment holding company principally engaged in the provision of clinical testing services. The Company operates nine segments. Hematology Testing segment includes testing services related to blood diseases. Genetic Diseases and Rare Diseases segment includes testing services from the rare disease. Infectious Diseases segment includes testing services from the infection department. Oncology segment includes testing related to oncology diseases. Neurology segment includes testing services related to neurological diseases undertaken by the Group. Maternity-related Diseases segment includes testing services related to maternity. COVID-19 Related Testing segment includes testing services related to COVID-19. Routine Testing segment conducts routine tests for the doctors’ daily diagnoses. The Others segment includes testing services for research and development (R&D) projects and others and miscellaneous services.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.47
Average target price
-
Consensus
  1. Stock
  2. Equities
  3. Stock Kindstar Globalgene Technology, Inc. - Hong Kong S.E.